COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)	12 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Weighted average discount rate	8.45%
Weighted average discount rate operating lease	9.12%
Interest rate	0.1019%	0.10%
Maturity years	7 years 1 month 6 days
Operating lease maturity years	9 years 8 months 12 days
Research and development expenses	$ 35,100,000
Net of discount	$ 11,600,000
Lease description	revised rate to be used upon adoption of ASC 842 of 10.19% compared to the previously used rate of 8.80%
Finance lease obligations, net of current portion	$ 200,000	$ 100,000
Weighted average time to maturity	17 years
Biologics License Application [Member]
Sublease rental income		39,000
Ergomed [Member]
Research and development expenses	$ 1,600,000	1,400,000.0
Net of discount	600,000	600,000.0
Clinical service trial	10,000,000
Additional clinical trial	$ 2,000,000
Weighted average time to maturity	7 years 1 month 6 days
TransactionTwoMember [Member] | October 1, 2019 [Member]
Change in right of use of assets and liability	$ 1,000,000.0
Cash paid related to operating leases	300,000	200,000
Net book value operating lease right of use assets	2,100,000	1,200,000
Current balance	100,000	100,000
Operating lease - liability	2,100,000	1,200,000
Operating lease expense	$ 200,000	200,000.0
Transaction One [Member] | October 1, 2019 [Member]
Weighted average discount rate	0.0845%
Change in right of use of assets and liability	$ 16,500,000
Current balance	600,000	900,000
Operating lease - liability	1,732,000	1,717,000
Finance lease liability	13,500,000
Net book value of the finance lease right of use asset	12,700,000	13,800,000
Balance of the finance lease liability	13,800,000	12,700,000
Cash paid related to finance leases	2,200,000	1,900,000
Cash paid related to finance leases interest	$ 1,200,000	1,200,000.0
Landlord [Member]
Interest rate	8.45%
Lease description	The repayment includes a base rent which escalates at 3% each year plus interest that accrues at 13.75% per year.
Lease incentive payable current	$ 1,600,000.0
Additional deposit	200,000
Cost incurred, initial	10,500,000
Estimated cost	10,700,000
Non current assets	1,900,000	$ 1,700,000
Financing arrangement	2,400,000
Vendor Obligations [Member]
Additional expenses	$ 1,100,000